IXI
iShares Global Consumer Staples ETF
🇦🇺 ASX
🇺🇸 UNITED STATES
👑 Overview
📈 Performance
📙 Holdings
💰 Distributions
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 4.04%
Annual Growth
5 years average annual growth
💰
2.61%
Annual distribution yield
Based on the most recent distribution
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
38
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
IXI.AX was created on 2006-09-12 by iShares. The fund's investment portfolio concentrates primarily on consumer staples equity. The fund aims to provide investors with the performance of the S&P Global 1200 Consumer Staples Sector Index, before fees and expenses. The index is designed to measure the performance of global consumer staples companies and may include large-, mid- or smallcapitalisation stocks.
📈 Performance
Price History
+83.80%
1M
1Y
10Y
Graph
Table
How could long term investing grow your wealth?*
Based on an initial investment of
$
and recurring investments every
for
$
Your wealth could grow to...
$68,198.23
after 5 years
$149,791.88
after 10 years
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →📙 Top Holdings
Show more
Updated as of 18 October 2024
Industry Exposure
📙 Other
100%
Country Exposure
🇺🇸 United States
100%
💰 Distributions
Payouts
💰 Annual Distribution Yield*
2.61%
💰 Annual Distribution Earnings Per $1,000 invested**
$26.11
💰 Most Recent Distribution Franked Percentage Estimate
0.00%
💰 Average Distribution Franked Percentage Estimate
0.00 %
💰 Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Estimate your distribution
If you held
$
of IXI, your last distribution payment(s) would have been:
$ 91.52
on Thu Jul 11 2024
$ 172.47
on Fri Jan 12 2024
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2024
$2.34
0.00%
2023
$1.80
0.00%
2022
$1.73
0.00%
2021
$1.71
0.00%
2020
$1.58
0.00%
2019
$1.61
0.00%
2018
$1.97
0.00%
2017
$2.45
0.00%
2016
$2.35
0.00%
2015
$2.27
0.00%
💵 Costs
💼
0.40%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$94.29
💰 Price To Earnings Ratio
0.00
💰 Price To Book Ratio
0.00
💰 Leveraged
No
💰 Inverse
No
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in IXI
38
📊 Total Capital Earnings
$78K
🔃 Average investment frequency
27 weeks
💵 Average investment amount
$2,899
⏰ Last time a customer invested in IXI
1 day
IXI investor breakdown
💵 Income of investors
More than 200k
8%
150k - 200k
11%
100k - 150k
23%
50k - 100k
19%
Less than 50k
34%
👶 Age of investors
18 - 25
26 - 34
21%
35 - 90
71%
🙋 Legal gender of investors
Female
34%
Male
66%
Pearlers who invest in IXI also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.85%
📊 Share price
$100.90 AUD
⛳️ DIVERSIFIED
🇦🇺 AUSTRALIA
🧱 MATERIALS
💸 FINANCIALS
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
18.86%
📊 Share price
$57.74 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
12.86%
📊 Share price
$129.54 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
24.86%
📊 Share price
$45.02 AUD
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.72%
📊 Share price
$66.53 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
Want more shares? Try these...
IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks
🙌 Performance (5Yr p.a)
10.41%
📊 Share price
$141.54 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
Ionic Rare Earths Ltd. is a mineral exploration company. The company is headquartered in Perth, Western Australia and currently employs 34 full-time employees. The firm is focused on developing its flagship Makuutu Rare Earths Project (Makuutu) towards production. The Makuutu comprises approximately six licenses covering approximately 298 square kilometers (km2) and is located over 40 kilometers east of the regional center of Jinja and approximately 120 kilometers east of the capital city of Kampala in eastern Uganda. The Company, through Ionic Technologies International Limited, has developed rare earth element (REE) separation and refining technology and applied this to the recovery and separation of individual rare earths from spent permanent magnets. The Company’s exploration license includes EL00257, EL00147 and EL00148. Its wholly owned subsidiary is Goldcap Resources Pty Limited. Its wholly owned subsidiary includes Ionic Technologies International Limited.
🙌 Performance (5Yr p.a)
-3.64%
📊 Share price
$0.01 AUD
⛏️ MINING
IWLD.AX was created on 2016-04-22 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global, developed market large, mid and smallcapitalisation companies
🙌 Performance (5Yr p.a)
10.99%
📊 Share price
$57.71 AUD
⛳️ DIVERSIFIED
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
Invex Therapeutics Ltd. is a biopharmaceutical company, which engages in the research and development of treatment for neurological conditions resulting from raised intracranial pressure. The company is headquartered in Perth, Western Australia. The company went IPO on 2019-07-05. The firm is focused on developing treatments for neurological conditions and focused on developing treatments for neurological conditions. Its primary focus is Idiopathic Intracranial Hypertension (IIH), a condition of predominately overweight women of childbearing age, which can lead to disabling headaches and, in some patients, permanent vision loss. The company has completed a Phase II trial. The Company’s lead program is the development of Presendin for IIH. Presendin is a once-per week, subcutaneous, sustained-release (SR) Exenatide microsphere formulation developed by Peptron, Inc. The firm is conducting a Phase III clinical trial (IIH EVOLVE) designed to meet the requirements for market approval of Presendin for the treatment of IIH in the European Union (EU), United Kingdom (UK) and Australia.
🙌 Performance (5Yr p.a)
-16.73%
📊 Share price
$0.09 AUD
📦 LOGISTICS